Andrew Perry

Insider Reports History

Entity
Individual
Location
C/O G1 Therapeutics, Inc., 700 Park Offices Drive, Suite 200, Research Triangle Park, NC
Signature
/S/ Monica Roberts Thomas, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Andrew Perry:

Stock Role Class Num Shares Value Price $ Report Date Ownership
G1 Therapeutics, Inc. Chief Commercial Officer Common Stock 0 $0 $2.51 Sep 18, 2024 Direct
G1 Therapeutics, Inc. Chief Commercial Officer Stock Option (right to buy) 0 Sep 18, 2024 Direct

Insider Reports Filed by Andrew Perry

Symbol Company Period Transactions Value $ Form Type Date Filed Role
GTHX G1 Therapeutics, Inc. Sep 18, 2024 5 $0 4 Sep 18, 2024 Chief Commercial Officer
GTHX G1 Therapeutics, Inc. Jul 5, 2024 1 -$3.35K 4 Jul 8, 2024 Chief Commercial Officer
GTHX G1 Therapeutics, Inc. Jul 1, 2024 1 $0 4 Jul 3, 2024 Chief Commercial Officer
GTHX G1 Therapeutics, Inc. May 13, 2024 1 -$39K 4 May 15, 2024 Chief Commercial Officer
GTHX G1 Therapeutics, Inc. Jan 3, 2024 4 -$7.53K 4 Jan 8, 2024 Chief Commercial Officer
GTHX G1 Therapeutics, Inc. Jul 5, 2023 1 -$871 4 Jul 7, 2023 Chief Commercial Officer
GTHX G1 Therapeutics, Inc. May 10, 2023 1 $0 4 May 12, 2023 Chief Commercial Officer
GTHX G1 Therapeutics, Inc. Jan 3, 2023 3 -$4.57K 4 Jan 5, 2023 Chief Commercial Officer
GTHX G1 Therapeutics, Inc. Jan 3, 2022 2 $0 4 Jan 5, 2022 Chief Commercial Officer
GTHX G1 Therapeutics, Inc. Aug 16, 2021 1 $0 4 Aug 17, 2021 Chief Commercial Officer
GTHX G1 Therapeutics, Inc. Aug 16, 2021 0 $0 3 Aug 17, 2021 Chief Commercial Officer